Skin News and Research

RSS

Study: Disrupting cancer pathway could extend benefits of new immunity-boosting drugs

Understanding how to overrule a signaling pathway that can cause treatments to fail in metastatic melanoma patients should help physicians extend the benefits of recently approved immunity-boosting drugs known as checkpoint inhibitors to more patients.

12 May 2015

OSU scientists develop more accurate method to evaluate cancer risk of pollutants

Scientists at Oregon State University have developed a faster, more accurate method to assess cancer risk from certain common environmental pollutants.

12 May 2015

Raising lupus awareness: an interview with Professor Ramsey-Goldman, MD

Lupus is a chronic, autoimmune disease, with many different symptoms so it is hard to diagnose. It affects each person differently and it has an unpredictable disease course with flare ups and quiet time. Some patients describe lupus as if they are riding a roller coaster with blinders on because they cannot always tell when they will feel well or sick...

11 May 2015

Southern Indiana to be oasis free from Lyme disease, finds Indiana University researcher

Over nearly 15 years spent studying ticks, Indiana University's Keith Clay has found southern Indiana to be an oasis free from Lyme disease, the condition most associated with these arachnids that are the second most common parasitic disease vector on Earth.

11 May 2015

Mixture of two anti-EGFR antibodies clinically active in treatment-resistant colorectal cancer

Patients with advanced colorectal tumors without mutations in the RAS genes derive substantial benefit from anti-EGFR therapies; however, the disease eventually progresses, leaving these patients with few alternative therapeutic options.

11 May 2015

Gene expression is key to understanding differences between individuals and predisposition to disease

The Genotype-Tissue Expression (GTEx) project consortia, which includes scientists from the Centre for Genomic Regulation (CRG) in Barcelona, have now published their results from their first pilot study in three Science papers...

8 May 2015

Full body dermatological scanner could help diagnose skin conditions in the future

Melanoma is aggressive and life-threatening. If it is not detected early, the prospects of recovery drop. Screening is complicated, though. Together with several project partners, Fraunhofer researchers have developed an assistance system that helps dermatologists with diagnosis.

8 May 2015

UC3M, IRYCIS patent new automated skin biopsy device

Universidad Carlos III de Madrid and the Institute for Health Research of the Hospital "Ramón y Cajal" have patented a new device for performing skin biopsies. With this new tool a skin biopsy can be performed with fewer instruments and the length of the procedure is shortened from thirty minutes to less than five.

8 May 2015

GTEx findings reveal how genomic variants can affect gene activity and disease susceptibility

Researchers funded by the National Institutes of Health Genotype-Tissue Expression (GTEx) project have created a new and much-anticipated data resource to help establish how differences in an individual's genomic make-up can affect gene activity and contribute to disease.

8 May 2015

Omega-3 fatty acids in fish oil can restore nerves damaged from diabetes

Approximately 50 percent of patients with diabetes suffer from nerve damage, or neuropathy. No cure exists, and the most effective treatment, keeping blood sugar in control, only slows neuropathy.

7 May 2015

New app may help parents save lives of premature babies

A new app launched by The University of Nottingham is offering parents of newborn infants the chance to play a crucial role in research that could save the lives of premature babies in the developing world.

7 May 2015

Researchers report novel approach to combat multidrug-resistant bacterial pathogens

With the threat of multidrug-resistant bacterial pathogens growing, new ideas to treat infections are sorely needed. Researchers at University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences report preliminary success testing an entirely novel approach -- tagging bacteria with a molecular "homing beacon" that attracts pre-existing antibodies to attack the pathogens.

7 May 2015

Cleaver Scientific launch safe series DNA electrophoresis products

The 'Safe' Series of products from Cleaver Scientific have been designed to make DNA electrophoresis procedures safer, more convenient and more economical to run.

From Cleaver Scientific Ltd 6 May 2015

NanoPass signs license agreement for supply of MicronJet600 device to Circassia

NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for vaccines, announced today that it has entered into a license agreement for the supply of MicronJet600, its microneedle delivery device, to Circassia Pharmaceuticals plc. (Oxford, UK), a specialty biopharmaceutical company focused on the allergy market.

6 May 2015

Cipher strengthens Canadian dermatology portfolio with acquisition of Vaniqa, Actikerall

Cipher Pharmaceuticals Inc. today announced it has strengthened its Canadian dermatology portfolio by acquiring the Canadian rights to Vaniqa and Actikerall from Almirall S. A., a Spanish pharmaceutical company. Both products have been approved by Health Canada.

6 May 2015

Luxembourg biologists provide complete image of human 'miRNome' in blood samples

In an elaborate study, biologists of the University of Luxembourg have found out that small molecules named microRNAs are, against many hopes, not yet suitable for early diagnosis of skin cancer, as well as supposedly for other types of cancer, in blood samples. For the first time they analysed all microRNAs in the serum of healthy people and thus provided a first complete image of the human "miRNome" in blood samples, in reference to the better-known "genome".

6 May 2015

First patient receives new 'resistance-busting' experimental skin cancer drug

A patient has become the first to receive a new 'resistance-busting' experimental skin cancer drug with the launch of a phase I clinical trial. The patient has received a new panRAF inhibitor - a new type of drug under development to address the problem of drug resistance in advanced skin cancer and a number of other cancer types.

6 May 2015

New Bio-Oil research demonstrates need for greater education on scar management

New research from Bio-Oil conducted amongst UK nurses demonstrates the need for greater education and resources on the management of patients with scarring following surgery or trauma.

6 May 2015

23andMe, Pfizer jointly launch Lupus Research Study

23andMe, Inc., the leading personal genetics company, today announced the launch of the Lupus Research Study in collaboration with Pfizer Inc. The companies aim to enroll 5,000 individuals with systemic lupus erythematosus, more commonly known as lupus, into the study to help better understand the genetics of lupus.

5 May 2015

Tuberous Sclerosis Alliance to observe fourth annual TSC Global Awareness Day

On May 15, the Tuberous Sclerosis Alliance (TS Alliance) will join tuberous sclerosis complex (TSC) organizations around the world to observe the fourth annual TSC Global Awareness Day.

5 May 2015

Skin News and Research

Study: Disrupting cancer pathway could extend benefits of new immunity-boosting drugs

OSU scientists develop more accurate method to evaluate cancer risk of pollutants

Raising lupus awareness: an interview with Professor Ramsey-Goldman, MD

Southern Indiana to be oasis free from Lyme disease, finds Indiana University researcher

Mixture of two anti-EGFR antibodies clinically active in treatment-resistant colorectal cancer

Gene expression is key to understanding differences between individuals and predisposition to disease

Full body dermatological scanner could help diagnose skin conditions in the future

UC3M, IRYCIS patent new automated skin biopsy device

GTEx findings reveal how genomic variants can affect gene activity and disease susceptibility

Omega-3 fatty acids in fish oil can restore nerves damaged from diabetes

New app may help parents save lives of premature babies

Researchers report novel approach to combat multidrug-resistant bacterial pathogens

Cleaver Scientific launch safe series DNA electrophoresis products

NanoPass signs license agreement for supply of MicronJet600 device to Circassia

Cipher strengthens Canadian dermatology portfolio with acquisition of Vaniqa, Actikerall

Luxembourg biologists provide complete image of human 'miRNome' in blood samples

First patient receives new 'resistance-busting' experimental skin cancer drug

New Bio-Oil research demonstrates need for greater education on scar management

23andMe, Pfizer jointly launch Lupus Research Study

Tuberous Sclerosis Alliance to observe fourth annual TSC Global Awareness Day

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News